Written Question·Department of Health and Social Care·UIN 28293

Trastuzumab Deruxtecan

Tabled: 3 February 2025

Answered: 11 February 2025

Question

Alison Bennett

To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of levels of access to Enhertu for cancer patients in (a) England, (b) Wales, (c) Northern Ireland and (d) Scotland.

Answer

Karin Smyth

No assessment has been made, as health is a devolved matter and decisions on the availability of medicines in Scotland, Wales, and Northern Ireland are a matter for their own administrations.Decisions on whether new medicines should be routinely funded by...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 28293) →